Munafa Stock Market Course + Intraday & FNO calls 
IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising
IONS NEWS reasons for why stock price of Ionis Pharmaceuticals, Inc. is falling or rising
IONS Ionis Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Ionis Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Ionis Pharmaceuticals IONS at this time. Stock is rising and might rise more.
It appears as if Ionis Pharmaceuticals IONS gave a large move recently.
Stock of Ionis Pharmaceuticals (IONS) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
My analysis of Ionis Pharmaceuticals is bullish for shortterm, and stock might move up till 81.4 or till 83.1. Use a stoploss of 80 and if this stock hits its stoploss, then it can fall down till 78.6
IONS Ionis Pharmaceuticals is falling or rising NEWS fundamental reasons
Manappuram Finance shares tumble 10% on report of RBI objections to Bain Capital deal Manappuram Finance shares fell 10% after a Reuters report said the RBI has objected to Bain Capital’s plan to acquire a controlling stake. Heavy volumes marked the sell-off as investors assessed regulatory risks surrounding the proposed investment. - NEWS as on 2026-01-09 indiatimes.com
2 top stock recommendations by Rahul Sharma Indian equity markets experienced sharp profit-taking, with the Nifty slipping below the crucial 26,000 mark and breaching 25,950, signaling heightened near-term volatility. Experts anticipate this uncertainty to persist until early next week, awaiting U.S - NEWS as on 2026-01-08 indiatimes.com
Client Associates sets Sensex's 2026 target at 93,918; sees elevated valuations, earnings moderation as headwinds Client Associates has set a December 2026 Sensex target of 93,918, implying 10% annual growth, while cautioning investors about elevated valuations and near-term earnings moderation, and highlighting gold and silver as strategic allocations amid global unc - NEWS as on 2026-01-07 indiatimes.com
Monthly SIP inflows double in three years as equity valuations stay elevated Indian savers are increasingly favoring Systematic Investment Plans (SIPs), with average monthly gross inflows more than doubling to ?28,202 crore in FY26. This surge, driven by robust equity fund returns and a preference for disciplined investing over lum - NEWS as on 2026-01-06 indiatimes.com
Commodity Radar: US-Venezuela tensions lift gold, but charts signal consolidation. Buy or sell? Domestic gold prices jumped 1.8% or over Rs 2,400 per 10 grams on Monday, driven by safe-haven demand amid the US–Venezuela conflict. COMEX gold rose 2.3% intraday, while MCX February futures traded near Rs 1,37,671, though prices remain below record highs - NEWS as on 2026-01-05 indiatimes.com
RBI lets existing non-compliant related-party transactions continue till maturity The Reserve Bank of India has issued new rules for related party transactions. Existing deals not meeting the new standards can continue until they mature. Equity investments are not included in these new directions. The RBI aims to prevent conflicts of in - NEWS as on 2026-01-05 indiatimes.com
Is the Options Market Predicting a Spike in EOG Resources Stock? Investors need to pay close attention to EOG Resources stock based on the movements in the options market lately. - NEWS as on 2026-01-04 nasdaq.com
2 top stock recommendations from Dharmesh Shah Indian markets begin 2026 with significant gains. The Bank Nifty has surpassed 60,000, and the broader Nifty is targeting 26,700. Market strategist Dharmesh Shah anticipates continued upward movement. Key stock recommendations include L&T and Adani Por - NEWS as on 2026-01-02 indiatimes.com
Sandeep Tandon on valuations, IPO hype and investor discipline Investors faced significant psychological challenges in 2025 due to extreme valuations and uneven market gains. Sandeep Tandon, CIO of Quant Mutual Fund, highlights the importance of emotional control and avoiding the trap of chasing momentum. While 2025 s - NEWS as on 2026-01-01 indiatimes.com
Nimesulide banned: Govt puts a stop to manufacture, sale of all oral formulations containing the popular painkiller above 100 mg Nimesulide sale banned: The move follows recommendation by India’s top research body- Indian Council of Medical Research (ICMR). In it’s earlier report to the drug regulatory body it had ecommended a total ban on all formulations of ninrsulide above 100 mg - NEWS as on 2025-12-31 indiatimes.com
Lenskart revenue can grow 6x in next decade, valuations look optically high: Emkay Emkay Global initiated coverage on Lenskart with a target price of Rs 525, citing strong long-term growth potential despite optically rich valuations. The brokerage expects robust revenue and earnings compounding driven by industry tailwinds, scale benefit - NEWS as on 2025-12-30 indiatimes.com
Do Options Traders Know Something About CNQ Stock We Don't? Investors need to pay close attention to Canadian Natural Resources stock based on the movements in the options market lately. - NEWS as on 2025-12-29 nasdaq.com
2 top stock recommendations from Rajesh Bhosale Dalal Street enters a subdued holiday mood as 2025 concludes, with benchmark indices struggling for momentum and trading sideways. Market experts suggest a 'buy on dip' strategy for Nifty and Bank Nifty, focusing on stock-specific opportunities, particular - NEWS as on 2025-12-29 indiatimes.com
FinMin asks banks, financial institutions to promptly report vigilance matters Public sector banks and financial institutions must now immediately report vigilance issues concerning their directors. The Finance Ministry issued this directive after instances where crucial adverse information was delayed. This includes private complain - NEWS as on 2025-12-28 indiatimes.com
Reset return expectations for SIPs to survive market fatigue; multi-asset allocation key in 2026: Nilesh Shah Kotak AMC MD Nilesh Shah says 2026 may deliver moderate equity returns as earnings recover and valuations normalise. SIP flows are likely to stay resilient if investors manage expectations. He backs multi-asset allocation, selective sector bets, and realis - NEWS as on 2025-12-26 indiatimes.com
KNR Constructions to exit 4 road projects; inks deal with Indus Infra Trust KNR Constructions is set to divest its entire stake in four highway special purpose vehicles to Indus Infra Trust. The deal is valued at Rs 1,543.19 crore. This strategic move involves the sale of 100 percent shareholding, including sub-debt. The transacti - NEWS as on 2025-12-25 indiatimes.com
Outlook 2026: Valuations comfort, AI reset could put India back on FII radar: Punita Kumar Sinha India’s equity outlook for 2026 looks brighter as valuations ease, domestic growth stays resilient and global investors reassess the crowded AI trade. Punita Kumar Sinha, Founding Partner of Pacific Paradigm Advisors explains why financials, selective IT, - NEWS as on 2025-12-24 indiatimes.com
Much-awaited Navi Mumbai International Airport set to commence operations on December 25 The City and Industrial Development Corporation (CIDCO), which is the implementing agency for the ambitious aviation project, in a release on Tuesday said the airport will have 30 Air Traffic Movements (arrivals and departures) on the first day of operatio - NEWS as on 2025-12-23 indiatimes.com
More announcements and NEWS
IONS Ionis Pharmaceuticals, Inc. current price & indicator signals
Recent prices of IONS Ionis Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 09 Fri Jan 2026 | 80.30 | 79.30 to 83.23 | -1.52% | 1.67 times |
| 08 Thu Jan 2026 | 81.54 | 79.94 to 83.79 | -1.96% | 1.28 times |
| 07 Wed Jan 2026 | 83.17 | 82.40 to 86.15 | 2.06% | 2.44 times |
| 06 Tue Jan 2026 | 81.49 | 78.00 to 81.54 | 3.77% | 1.66 times |
| 05 Mon Jan 2026 | 78.53 | 76.08 to 79.42 | -1.43% | 0.91 times |
| 02 Fri Jan 2026 | 79.67 | 78.02 to 80.21 | 0.71% | 0.88 times |
| 31 Wed Dec 2025 | 79.11 | 78.63 to 79.84 | 0.18% | 0.69 times |
| 30 Tue Dec 2025 | 78.97 | 78.52 to 79.99 | -1.26% | 0.72 times |
| 29 Mon Dec 2025 | 79.98 | 78.74 to 80.04 | 0.06% | 0.67 times |
| 26 Fri Dec 2025 | 79.93 | 79.18 to 80.42 | -0.89% | 0.45 times |
| 24 Wed Dec 2025 | 80.65 | 80.33 to 81.02 | 0.4% | 0.3 times |
| 23 Tue Dec 2025 | 80.33 | 79.63 to 81.84 | -1.24% | 0.77 times |
Videos related to: IONS NEWS why is Ionis Pharmaceuticals, Inc. price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
